Endurance shuttle walking test: responsiveness to salmeterol in COPD

Brouillard C., Pepin V., Milot J., Lacasse Y., Maltais F.

Source: Eur Respir J 2008; 31: 579-584
Journal Issue: March
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Brouillard C., Pepin V., Milot J., Lacasse Y., Maltais F.. Endurance shuttle walking test: responsiveness to salmeterol in COPD. Eur Respir J 2008; 31: 579-584

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Tiotropium improves walking endurance in COPD
Source: Eur Respir J 2012; 39: 265-271
Year: 2012



Endurance shuttle walking test: response to salmeterol in chronic obstructive pulmonary disease
Source: Annual Congress 2007 - Mechanisms and new treatments of COPD
Year: 2007


Comparing interval and continuous endurance training in COPD
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005


Exercise training progression: assessing performance change
Source: Annual Congress 2006 - PG18 - Basic principles of pulmonary rehabilitation
Year: 2006



Differences between walking and stair climbing in severe COPD patients receiving and not receiving long-term NIV
Source: Annual Congress 2007 - Physiological effects of noninvasive ventilation
Year: 2007



Salmeterol/fluticasone propionate (SFC) improves the inspiratory to total lung capacity ratio (IC/TLC) and exercise endurance time in patients with COPD
Source: Annual Congress 2006 - COPD therapy
Year: 2006


Exercise and dyspnoea in COPD
Source: Eur Respir Rev 2006; 15: 72-79
Year: 2006



Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: 564-569
Year: 2002



Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients
Source: Eur Respir J 2001; 18: 77-84
Year: 2001



Exercise capasity and respiratory muscle strength responces to the cycle ergometer and calisthenic exercise training in chronic obstructive pulmonary diseases
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013


Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: 86-94
Year: 2004



Effect of 8 and 12 weeks’ once-daily tiotropium and olodaterol, alone and combined with exercise training, on exercise endurance during walking in patients with COPD
Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations
Year: 2016


Dynamic hyperinflation during the 6-minute walk test and incremental cycling exercise in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 121s
Year: 2004

Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD
Source: Eur Respir J 2009; 34: 866-874
Year: 2009



Exercise performance: limitations and trainability
Source: Annual Congress 2006 - PG18 - Basic principles of pulmonary rehabilitation
Year: 2006



Exercise testing in the evaluation of interventions
Source: Annual Congress 2007 - PG12 - Cardiopulmonary exercise testing and interpretation
Year: 2007



Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD
Source: Eur Respir J 2009; 33: 771-777
Year: 2009



Mechanisms limiting exercise in COPD: new insights
Source: Annual Congress 2005 - Mechanical factors limiting physical exercise in disease
Year: 2005

Effects of aclidinium bromide on exercise endurance, dynamic hyperinflation, physical activity and exertional dyspnoea in patients with moderate to severe COPD
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013